Table of Contents
I. Registration and Call for Abstracts for May 16-17, 2023, NIDA Genetics and Epigenetics Meeting, Natcher Conference Center, NIH, Bethesda MD
II. Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain (NOT-DA-20-039)
IV. Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed) (NOT-DA-22-064)
V. Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed) (RFA-DA-24-027)
VI. Job Opening for Data Science (Neuroinformatics) Program Officer https://www.usajobs.gov/job/704383400
VII. Learn More About the National Institute on Drug Abuse (NIDA) https://nida.nih.gov/
I. Registration and Call for Abstracts for May 16-17, 2023, NIDA Genetics and Epigenetics Meeting, Natcher Conference Center, NIH, Bethesda MD
You are invited to register and/or submit an abstract for the NIDA Genetics and Epigenetic Meeting to be held at Natcher Conference Center, Bldg. 45, on the NIH Campus in Bethesda, MD. This is an in-person meeting.
To register: https://apps1.seiservices.com/NIDA/GeneticsConsortium/Default.aspx
To submit an abstract:
https://apps1.seiservices.com/NIDA/GeneticsConsortium/docs/2023-AbstractForms_508c.pdf
Abstracts are due by Midnight PST on March 3, 2023
There is no registration fee to attend this meeting. However, attendees are responsible for their own
travel, meals, and lodging.
The goals of the meeting are to:
• Showcase the exciting research on the genetics and epigenetics of substance use disorders.
• Encourage collaboration among investigators with different expertise in genetics and
epigenetics.
• Foster collaboration between investigators working on the genetics and epigenetics of
substance abuse disorders and HIV/AIDS investigators.
• Identify new research opportunities in the genetics and epigenetics of substance use
disorders.
• Provide attendees with an opportunity to meet with NIDA program directors to discuss their ideas for grant applications and funding opportunities.
I. Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain (NOT-DA-20-039)
The purpose of this Notice is to encourage investigators to submit grant applications to the National Institute on Drug Abuse (NIDA)to study the effects of cannabis and cannabinoid exposure on the developing brain, from pre-, peri-, and post-natal development through young adulthood in humans and using animal models.
Application due dates: Standard dates apply by 5:00 PM local time of applicant organization.
This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the effects of an overdose and the observed toxicities caused by acute Ultra-Potent Synthetic (UPS) opioid exposure. This FOA will also support mechanistic studies of persistent or delayed pathophysiological effects be acute exposure to UPS opioids. This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the effects of an overdose and the observed toxicities caused by acute Ultra-Potent Synthetic (UPS) opioid exposure. This FOA will also support mechanistic studies of persistent or delayed pathophysiological effects after acute exposure to UPS opioids.
Application Due Date (New and Renewal/Resubmission/Revision):
November 17, 2023, and November 19, 2024
Link to the RFA:
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-056.html
III. Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed) (NOT-DA-22-064)
The National Institute on Drug Abuse intends to promote a new resource access program by publishing a Funding Opportunity Announcement (FOA) to seek applications for the following: NIH Brain Development Cohorts (NBDC) Biospecimen Access Program (X01- Clinical Trial Not Allowed). This FOA will allow investigators to apply for access to biological samples from the Adolescent Brain Cognitive DevelopmentSM (ABCD) Study. By making these specimens available to the greater scientific community, this resource award seeks to maximize the scientific potential of the biospecimens collected in the ABCD Study® and expand the scope of ABCD’s open science model, allowing scientists from around the world to utilize these specimens and enrich the child and adolescent health data being obtained from the ABCD Study.
No funds will be provided through this opportunity. Applicants will be responsible for costs associated with conducting the research and sample shipment. Applicants will need to submit proof of funding for costs of analyses and sample shipment at the time of application.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The FOA is expected to be published in Spring 2023 with an expected application due date in Summer 2023.
This FOA will utilize the X01 activity code. See notice for more details of planned FOA.
IV. Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed) (RFA-DA-24-027) This FOA will support creative educational activities with a primary focus on methodological rigor in the analysis of large complex datasets involving brain, behavior, genomic, and socioenvironmental data. This could involve:
Courses for Skills Development: For example, advanced statistics and research design courses in a specific discipline or research area, rigor and robustness in research practice, or ethical conduct of biomedical research.
Curriculum or Methods Development: For example, to improve biomedical, behavioral or clinical science education, or develop novel instructional approaches or computer-based educational tools that support methodological rigor in analysis of large complex datasets.
Objectives:
This Funding Opportunity Announcement (FOA) encourages applications that seek to advance methodological rigor in biomedical and behavioral research by supporting training on the responsible analyses of complex, large-scale datasets involving brain, behavioral, genomic, and socioenvironmental data.
Topics of interest include, but are not limited to:
Analytical approaches for large-scale, longitudinal data
- Enhanced rigor and robustness in research practice (e.g., pre-registration of experimental protocols, plans, and analyses)
- Estimation of meaningful associations, including population inferences, effect sizes, control of covariates, and interpretation of associations
- Ethical conduct of biomedical and behavioral research, including consideration of social constructs such as race/ethnicity and gender, and the potential for stigmatization
- Community-partnered research to inform data analyses and interpretation
- Consideration of socioenvironmental contexts known to introduce inequities, such as family income and education, employment, housing, neighborhood-level characteristics, and exposure to violence
- Factors to consider when examining the influence of socioenvironmental factors (e.g., non-random data missingness, sampling methodologies)
In addition, NIDA emphasizes responsible analyses of data related to neurodevelopment and neurocognition, as it relates to the substance use trajectory.
Research education programs may complement ongoing research training and education occurring at the applicant institution, but the proposed educational experiences must be distinct from those training and education programs currently receiving Federal support. R25 programs may augment institutional research training programs (e.g., T32, T90) but cannot be used to replace or circumvent Ruth L. Kirschstein National Research Service Award (NRSA) programs.
Application Deadline: February 8, 2024, 5:00 PM local time of applicant organization.
V. Job Opening for Data Science (Neuroinformatics) Program Officer
To apply: https://www.usajobs.gov/job/704383400
The National Institute on Drug Abuse (NIDA), Division of Neuroscience and Behavior (DNB), Office of the Director is currently recruiting for a data science Program Officer. The mission of the Division of Neuroscience and Behavior is to discover, facilitate and promote outstanding basic animal and human research supporting the mission of NIDA, to identify the causes and consequences of drug addiction and misuse across the lifespan and to guide treatment strategies. DNB develops and supports an extramural research program that will advance the understanding of the genetic, chemical, neurobiological and behavioral mechanisms of addictive drugs and their long-term consequences. Research related to the neurobiological bases of reward and the behaviors that characterize the cycle of addiction are a primary focus of DNB. Additionally, an integral component of DNB’s scientific mission is to grow and maintain a diverse workforce that is dedicated to these research goals and is supported through training initiatives that span from predoctoral level to mid-stage investigator. The Office of the Director directs, coordinates, and supports the Division’s missions and activities through maintaining and evaluating strategic directions and goals, supporting goals through the branch structure, and developing and leveraging collaborations and activities across NIDA and NIH.
The data science Program Officer would be responsible for assisting in the management of a research portfolio of grants using data science approaches to advance science on the causes of consequences of drug use and addiction. Additionally, the grant portfolio would include data curation, sharing, access, reproducibility, security, analysis, harmonization, quality metrics and standards, and visualization. The data science program officer would also serve as a representative for NIDA on NIH-wide and multi-agency committees.
For additional information about this position, please contact Dr. Roger Little, alittle@mail.nih.gov
VI. Learn More About the National Institute on Drug Abuse (NIDA) https://nida.nih.gov/
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
No comments:
Post a Comment